M&A Deal Summary |
|
---|---|
Date | 2022-01-14 |
Target | Stirling Anglian |
Sector | Life Science |
Buyer(s) | Kelso Pharma |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Kelso Pharma is a business committed to bringing innovative specialty medicines to the European healthcare markets, to provide meaningful benefits to patients and create added value for healthcare stakeholders.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
Country (United Kingdom) | 1 of 1 |
Year (2022) | 1 of 1 |